Cetera Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Cetera Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,330	Closed	-$19K	–	1688
2022 Q3	$19K	Buy	16,330 +6,000	+58%	+$9.35K	﹤0.01%	1250
2022 Q2	$19K	Buy	+10,330	New	+$15.2K	﹤0.01%	1344
2022 Q1	–	Sell	-14,030	Closed	-$38K	–	1551
2021 Q4	$38K	Buy	+14,030	New	+$51.9K	﹤0.01%	1411

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cetera Advisors's CLVS Position: Q4 2022 in Review

Cetera Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 16,330 shares — an estimated $19K sold.

Cetera Advisors first reported a position in CLVS in Q4 2021 and held it in 3 quarters. The position peaked at $38K in Q4 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Cetera Advisors reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Cetera Advisors sold 16,330 Clovis Oncology, Inc. shares in Q4 2022, an estimated $19K.
Cetera Advisors first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 3 quarters.
Cetera Advisors's Clovis Oncology, Inc. position peaked at $38K in Q4 2021.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Cetera Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.